Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - COST OF REVENUE
Cost of Revenue APLS - Apellis Pharmaceuticals, Inc.
58.5 M
LAST VALUE
235.44%
2 YEAR CAGR
-14.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR